The EASL SLD Summit 2025 has come to a close, we want to express our heartfelt gratitude to our delegates, faculty, organisers, and sponsors for your active engagement and enthusiasm throughout this extraordinary event! The SLD Summit counted 518 delegates…
Over three inspiring days in Rotterdam and online, we explored the latest in liver cancer care, from new research on primary liver tumours to innovative treatment strategies. If you have attended the meeting, you can claim 12.5 CME credits. All…
On the 25th April, 9:30 to 10:30 CET, the European Association for the Study of the Liver (EASL) together with with the ACHIEVE Coalition organise a webinar on the EU Health Policy Platform, to discuss the needed actions to collectively…
EASL`s vision is to beat liver disease. This event, held in partnership with AASLD, ALEH, APASL and SOLDA on the sidelines of the 76th World Health Assembly (WHA76) represents the first-time policymakers, Permanent Mission Representatives to the UN in Geneva,…
On the 25th October, EASL together with the ACHIEVE Coalition, organise an event at the European Parliament with the members of the EASL Friends of the Liver Group on the occasion of Liver Cancer Awareness month. The discussion will focus…
As we draw the curtains on the EASL SLD Summit 2023, we extend our sincere thanks to each and every one of you for your participation and unwavering enthusiasm throughout this remarkable event. Your active participation has been instrumental in advancing our…
The pathophysiology of the biliary tree and its epithelium continues to attract strong interest. In fact, cholangiopathies (diseases of the biliary tree) represent an important cause of morbidity and mortality, and a relevant indication for liver transplantation in both the…
